Wobble Genomics is a pioneering healthcare and biotechnology company specialising in long-read RNA sequencing. Its innovative Level-Up biochemical technology enhances the detection of low-abundance RNA sequences, allowing scientists to capture all unique full-length RNA sequences in any sample. Paired with its TAMA bioinformatic technology, Wobble optimises the identification of low-level signals, using RNA biology to drive deeper insights from sequencing data
Company Details
- Employees
- 22
- Founded
- 2021
- Address
- Edinburgh, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.wobblegenomics.com
- Keywords
- Leicester.
- HQ
- Edinburgh
Wobble Genomics Ltd Questions
Wobble Genomics Ltd's website is https://www.wobblegenomics.com
Wobble Genomics Ltd's LinkedIn profile is https://uk.linkedin.com/company/wobble-genomics
Wobble Genomics Ltd has
22 employees.
View email and phone details for 22
employees at Wobble Genomics Ltd.
Wobble Genomics Ltd's industry is
Biotechnology Research
Wobble Genomics Ltd's top competitors are
Mercia Asset Management Plc,
Dxcover,
Enhanced Genomics,
Clearnote Health,
Revolugen Ltd,
Eximius Diagnostics Corporation,
Aureum Diagnostics Limited,
Roslin Institute,
Carcinotech,
Predictiva.
Wobble Genomics Ltd's categories are Biotechnology Research
Wobble Genomics Ltd's founding year is 2021
